Skip to content

Effect of local administration of Esketamine on postoperative sore throat after thyroidectomy : a randomized controlled study

Effect of local administration of Esketamine on postoperative sore throat after thyroidectomy : a randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072297
Enrollment
Unknown
Registered
2023-06-08
Start date
2023-06-08
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative sore throat

Interventions

Ketamine Group 1:Before intubation, use a laryngeal anesthesia tube and spray the larynx with ketamine (4 mg diluted to 3 ml)
Ketamine Group 2:Before intubation, use a laryngeal anesthesia tube and spray the larynx with ketamine (2 mg diluted to 3 ml)
Saline Group:Saline (3 ml) was sprayed before intubation

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Intended thyroidectomy under general anesthesia patient, communication normal, signed informed consent, age 18-65 years, female.

Exclusion criteria

Exclusion criteria: ?A history of ketamine or esketamine allergy;?severe heart disease, liver and kidney dysfunction;?Airway difficulty or history of maxillofacial and neck surgery;?Chronic respiratory diseases (such as chronic obstructive pulmonary disease or asthma), recent respiratory infections, chronic cough, and current smoking;?A history of sore throat within two weeks;?Preoperative use of non-steroidal anti-inflammatory drugs or opioid analgesics; Patients who are receiving calcium channel blockers or magnesium therapy;?Reoperation due to serious adverse events such as bleeding;?Anesthesia lasted more than 4 hours;?Patients with delayed extubation (no extubation for more than 1 hour) or transfer to intensive care unit (ICU) due to adverse effects of experimental drugs. All subjects signed written informed consent.

Design outcomes

Primary

MeasureTime frame
postoperative sore throat;

Secondary

MeasureTime frame
Postoperative hoarseness;Postoperative complications: postoperative agitation, nausea and vomiting, dysphagia, psychiatric symptoms, etc;

Countries

China

Contacts

Public ContactChen lijian

Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University

chenlijian77@126.com+86 139 6669 9467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026